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Early detection and timely correction of coagulopathy are crucial in preventing further exacerbation of bleeding diathesis and in breaking the vicious cycle of coagulopathy during LT, in addition to improving overall patient outcomes.
Rotation thromboelastometry (ROTEM w delta, TEM International GmbH, Munich, Germany) is a point-of-care coagulation monitoring system that evaluates the viscoelasticity of whole blood, allowing the entire clotting process, from clot initiation and formation to clot stability, to be assessed. 5 6 In contrast to conventional laboratory tests [e.g. measurements of platelet count (PLT), prothrombin time (PT), activated partial thromboplastin time (aPTT), and fibrinogen concentration (Fib)], ROTEM w can measure early variables, such as clot amplitude at 5 min (A5) and 10 min (A10) after clotting time (CT) in EXTEM, INTEM, and FIBTEM. Owing to its rapid assessment of PLT and Fib, ROTEM w is frequently used to guide transfusion therapy. 7 -10 Moreover, a recent study with a large database demonstrated that early measures of clot firmness, including A5, A10, and clot amplitude at 15 min (A15), are linearly correlated with ROTEM w determined maximum clot firmness (MCF), allowing the fast and reliable prediction of MCF in non-cardiac patients, including those with subnormal, normal, and supranormal MCF values. 11 The A10 of EXTEM (A10 EXTEM ) was shown to be rapid and valuable in predicting coagulation status, and also being useful in assessing the need for perioperative transfusion of platelets and fibringen. 8 The correlations of the more rapid A5 with PLT count and Fib concentration have not been determined, and it remains unclear whether A5 could determine quantitative PLT and Fib level in hypocoagulable patients undergoing living-donor LT (LDLT) surgery. We therefore assessed whether A5 on ROTEM analysis is an early and reliable index for the transfusion of PLT and Fib during LDLT. We also assessed A5 cut-off values predicting thrombocytopenia and hypofibrinogenaemia in patients undergoing LDLT. 
Methods

Patients
Anaesthetic technique
General anaesthesia for LDLTsurgery was performed according to our institutional standard protocol. 12 Briefly, anaesthesia was induced with i.v. thiopental, fentanyl, and vecuronium, and maintained with 1% sevoflurane, a 50% O 2 /air mixture, and continuous infusion with fentanyl and vecuronium. Twenty-gauge femoral and radial arterial catheters were inserted to monitor arterial pressure and to sample blood. A 7.5 French pulmonary artery catheter (Swan-Ganz CCOmbo V CCO/SvO 2 /CEDV, Edwards Lifesciences LLC, CA, USA) was inserted to monitor haemodynamic variables. Body temperature was measured using a thermistor in a pulmonary artery catheter. Transfusions of packed red blood cells, fresh-frozen plasma, and cryoprecipitate were based on clinical decisions or guided by standard laboratory tests or the transfusion algorithm based on ROTEM parameters. According to institutional standards, transfusions were administered to maintain PT,2.0 INR, Fib.100 mg dl 21 , and PLT.30 000 mm
23
. Synthetic colloidal solution was not used, but solutions of 5% albumin with balanced crystalloid were administered during LDLT.
Blood sampling and thromboelastomery
During LDLT, standard coagulation assays and ROTEM w tests were routinely performed, using blood samples at pre-established time points, including 1 h after induction of general anaesthesia, 1 h after surgical incision, 30 min after hepatectomy, and 30 min after graft reperfusion and after hepatic artery anastomosis. ROTEM w tests were performed according to the manufacturer's instructions, using equipment and test reagents provided by Tem International GmbH. The ROTEM w device was placed in the operating theatre and all tests were performed by transplantation anaesthesiologists or anaesthesia nurses trained to perform ROTEM w tests. Of the ROTEM w tests performed, inadequate runtime, patients who received thrombin inhibitor or signs of hyperfibrinolysis were excluded. Finally, 1139 EXTEM, 1182 INTEM, and 1125 FIBTEM tests were included in the study. ROTEM w variables recorded included: (i) clotting time (CT), defined as the time (s) from the start of measurement to the initiation of clotting, defined as a clot firmness of 2 mm; (ii) clot formation time (CFT), defined as the time (s) from initiation of clotting until a clot firmness of 20 mm; (iii) MCF, defined as the maximal amplitude (mm) of the graphical trace of clot firmness; (iv) a-angle (a), defined as the tangent to the graphic trace at an amplitude of 2 mm; and A5 and A10 (mm), which reflect the amplitudes 5 and 10 min, respectively, after CT. At each time point, blood samples were withdrawn from the radial artery, and haemoglobin, PT, PLT, and Fib were measured.
Standard coagulation assays
PT was assessed using Thromborel S kits (Siemens Healthcare Diagnostics, GmbH, Marburg, Germany), and fibrinogen was assayed using the Dade Thrombin Reagent (Siemens Healthcare Diagnostics). All tests were performed using an automatic coagulation analyser (Sysmex CA-7000, Siemens Healthcare Diagnostics).
Statistical analyses
Continuous variables were expressed as median (inter-quartile range) or mean [standard deviation (SD)]. Between-group comparisons were evaluated using the x 2 test, Fisher's exact tests, t-tests, and Mann-Whitney U-tests, as appropriate. Correlations between standard coagulation test results and those performed on ROTEM w were analysed using Spearman's rank correlation coefficient (r). The Bland-Altman analyses 13 were performed to estimate the mean difference (bias) (SD) between early measures of clot firmness (A5 and A10) and MCF. Receiver operating characteristic (ROC) curves and the area under the Figure 1 . Among the ROTEM w parameters, both A5 EXTEM (r¼0.961, P,0.0001) and A10 EXTEM (r¼0.975, P,0.0001) were highly correlated with MCF EXTEM , and also with MCF INTEM (r¼0.950 and r¼0.965, respectively; P,0.0001 each). In addition, A5 FIBTEM (r¼0.907, P,0.0001) and A10 FIBTEM (r¼0.951, P,0.0001) showed high correlation with MCF FIBTEM .
Intraoperative ROTEM w data and biases calculated from the Bland -Altman analyses of A5 and A10 for EXTEM, INTEM, and FIBTEM parameters are shown in Table 2 . Intraoperative trends of ROTEM w data and laboratory parameters are shown in Figure 2 . Because the scatterplot seemed to follow a curvilinear relationship between ROTEM w data and conventional coagulation parameters, we performed both linear and curvilinear fitting (Fig. 3) . The curvilinear fits showed better correlations for all comparisons. A5 EXTEM , A10 EXTEM , and MCF EXTEM showed better correlations with PLT (r¼0.76, r¼0.76, and r¼0.75, respectively, P,0.001 each) than with Fib (r¼0.63, r¼0.65, and r¼0.63, respectively, P,0.0001 each), indicating that MCF parameters are explained better by PLT than by Fib. In addition, A5 INTEM , A10 INTEM , and MCF INTEM showed good correlations with PLT (r¼0.77, r¼0.77, and r¼0.75, respectively, P,0.001 each) and Fib (r¼0.64, r¼0.66, and r¼0.62, respectively, P,0.0001 each), and A5 FIBTEM , A10 FIBTEM , and MCF FIBTEM were correlated with Fib (r¼0.75, r¼0.76, and r¼0.75, respectively, P,0.0001 each) (Fig. 3) .
ROC curve analysis showed that the cut-off values of A5 EXTEM and A10 EXTEM predicting PLT,30 000 mm 23 were 15 mm (sensitivity: 86%, specificity: 77%) and 22 mm (sensitivity: 85%, specificity: 78%), respectively, and that their cut-off values to predict PLT,50 000 mm 23 were 19 mm (sensitivity: 82%, specificity: 78%) and 27 mm (sensitivity: 82%, specificity: 77%), respectively. AUCs of A5 EXTEM and A10 EXTEM were 0.90 and 0.898, respectively, for PLT,30 000 mm 23 and were 0.871 and 0.867, respectively, for PLT,50 000 mm 23 (all P,0.0001) (Fig. 4) . (Fig. 4) .
Discussion
The first major finding of our study was that all correlations and ROC curve analyses, including AUCs, were very similar for A5 EXTEM during LT. 8 15 Because conventional laboratory tests have long turnaround times in clinical settings, determining when to start a transfusion and the amounts of allogeneic blood products transfused into patients with massive bleeding is difficult. Therefore, early variables assessed by point-of-care ROTEM device, which are available within 10 -20 min, have been increasingly used to trigger transfusion of platelets and fibrinogen-rich products. Trigger values were based on evidence that these variables could successfully determine thrombocytopenia and hypofibrinogenaemia in patients undergoing LT and cardiac surgery and those with severe We observed biases between early variables (A5 and A10) and MCF of ROTEM w analyses. Because the median values of MCF EXTEM , MCF INTEM , and MCF FIBTEM were 37, 37, and 6 mm, respectively, our data characterize patients with subnormal MCF. In EXTEM and INTEM assays, the biases between A5 and A10 and MCF were 16 and 9 mm, respectively. Therefore, to T0  T0  T1  T2  T3  T4  T0  T1  T2  T3  T4  T1  T2  T3  T4   200 19 Thirdly, differences in the use of colloids might have an effect on the observed bias, particularly for FIBTEM. Synthetic colloids such as hydroxyethyl starch solutions are known to have an impact on fibrin polymerization, resulting in decreased MCF. 20 21 However, as we used only albumin for colloid solution during LDLT, our data would not be affected by synthetic colloids in the bias between early variables of clot firmness (A5 and A10) and MCF. This difference might result in increased bias between A5 (A10) and MCF, in particular in FIBTEM, between our study and the earlier study. 11 Taken together, because of the potentials for selection and observation biases among different studies (e.g. differences in gender, ethnicity, clinical conditions, types of fluid replacement, etc.), care should be taken when interpreting the results of bias between early variables (A5 and A10) and MCF of ROTEM w analyses. Our study had several limitations. First, it was a retrospective, single-centre study, suggesting caution in interpreting our results as there might have been observation bias and bias in patient selection. Secondly, we did not assess the predictability of transfusion requirements based on ROTEM w analysis or standard coagulation tests. Further studies are needed to evaluate whether threshold levels of ROTEM w parameters can estimate clinical bleeding and guide transfusion therapy to improve treatment of haemostatic derangements associated with LDLT.
In conclusion, our findings indicate that A5 as an early variable of clot firmness in thromboelastometry is effective to detect thrombocytopenia and hypofibrinogenaemia in hypocoagulable patients undergoing LT. A5 on ROTEM w analysis might be the earliest, most reliable index in selecting transfusion guidelines based on PLT and Fib during LDLT.
